Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "conference"
Home
'Why Travel to Seoul for Emergency Stroke Care?': S Pohang Hospital’s 18-Year Mission
Two weeks before his daughter’s wedding, a middle-aged man was rushed to the hospital after suffering sudden paralysis from an acute stroke.
09/07/2026, 03:54 ET
Severe MRI Findings Don’t Automatically Require Spine Surgery: 3 Factors Doctors Check First
A patient undergoes a magnetic resonance imaging scan and is told that their spinal canal has "significantly narrowed" or that a "large herniated...
09/04/2026, 07:43 ET
Leg Pain Persists After Back Surgery? A 'Hidden Lesion' May Be the Culprit
When pain or numbness in the buttocks and legs persists after spinal surgery, it does not automatically indicate that...
09/01/2026, 07:16 ET
Single Abdominal Ultrasound Can Gauge Liver Cancer Risk in Fatty Liver Patients, Study Finds
Fatty liver disease is one of the most common findings during routine health screenings.
08/30/2026, 23:49 ET
A Third Arm for Therapists: The Surgeon Bringing ‘Self-Driving’ Tech to Physical Rehab
Artificial intelligence may be able to detect a patient’s disease, but it cannot move stiff arms and legs for them.
08/21/2026, 02:20 ET
Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars
Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and...
08/20/2026, 01:54 ET
VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial
Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by...
08/12/2026, 23:23 ET
Daewoong Pharmaceutical’s Nabota Enters Kuwait, Expanding Middle East Footprint to Seven Countries
Daewoong Pharmaceutical’s botulinum toxin product Nabota has entered Kuwait, expanding its Middle East footprint to...
07/31/2026, 21:02 ET
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data
HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
07/26/2026, 08:54 ET
Daegu Wins Bid to Host 2034 World Congress of Basic & Clinical Pharmacology
Daegu has been selected to host the 2034 World Congress of Basic & Clinical Pharmacology (WCP 2034), marking the first...
07/26/2026, 08:05 ET
Previous
1
2
3
4
5
Next